2Arnold FW, Summersgill JT, Lajoie AS, et al. A world- wide perspective of atypical pathogens in community-ac- quired pneumonia[J]. Am J Respir Crit Care Med, 2007, 175(10) . 1086-1093.
3Nqeow YF, Suwanjutha S, Chantarojanasriri T, et al. An Asian study on the prevalence of atypital respiratory pathogens in community-acquired pneumonia[J]. Int J Infect Dis,2005,9(3) :144-153.
4Eun BW, Kim NH, Choi EH, et al. Mycoplasma pneumon- iae in Korean children:The epidemiology of pneumonia o- ver an 18-year period[J]. J Infect,2008,56 (5) 326-331.
5Grabowska-Krawiec P. Contemporary risks of infections by Myeoplasma pneumoniae and Chlamydophila pneu- moniae[J]. Pol Merkur Lekarski, 2012, 33 (197) . 270- 273.
6Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special refer- ence to pneumonia[J]. J Infect Chemother, 2010,16 (3) . 162-169.
7Bebear C,Pereyre S, Peuchant O. Mycoplasma pneumoni- ae:susceptibility and resistance to antibiotics[J]. Future Microbiol, 2011,6 (4) :423-431.
8Liu Y, Ye X, Zhang H, et al. Antim icrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analy- sis of macrolide-resistant strains from Shanghai China [J]. Antimicrob Agents Chemother, 2009,53 ( 5 ) . 2160- 2162.
9Morozumi M,Takahashi T,Ubukata K. Macrolide-resist- ant mycoplasma pneumoniae., characteristics of isolates and clinical aspects of community-acquired pneumonia [J]. J Infect Chemother, 2010,16 (2) : 78-86.
10Morozumi M,Iwata S, Hasegawa K, et al. Increased mac- rolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia[J]. Antimi- crob Agents Chemother, 2008,52 (1) : 348-350.
